Chief Executive Officer and Director
Ken d’Entremont is the founder, president, and CEO of Medexus Inc. Previously, he was the general manager and vice president of business development at Sanofi, where he led the in-licensing initiatives for Sanofi Canada. Mr. d’Entremont holds a Bachelor of Science in Chemistry from McMaster University.
Chief Financial Officer
Roland Boivin was appointed as CFO of Pediapharm on July 1, 2013. He has held several management positions at 3M Canada, was a member of the company’s executive leadership team, and had overall responsibility of the consumer division. Mr. Boivin holds a Bachelor of Commerce from McGill, a Master of Business Administration from Queen's University, and is a certified Six Sigma Black Belt.
President, U.S. Operations
Terri Shoemaker was president and CEO of Medac Pharma from inception until October 2018 when the company was acquired by Medexus. Previously, Ms. Shoemaker was the vice president of sales at InterMune, co-founder of BioPharm SS, and held various other roles at Pharmion, Celgene, and Dupont Pharmaceuticals. Ms. Shoemaker holds a Bachelor of Science in Communication Science from Missouri State and Master of Science in Communication Science and Disorders from the University of Central Missouri.